非酒精性脂肪性肝病患者慢性肾脏病的发生:一项队列研究
该回顾性队列研究纳入41,430名基线无慢性肾脏病(CKD)的成人,随访中位4.15年,发现非酒精性脂肪性肝病(NAFLD)与CKD发生风险升高相关(多因素校正HR 1.22,95%CI 1.04-1.43),且NAFLD纤维化评分(NFS)≥-1.455者风险更高(HR 1.58,95%CI 1.30-1.92)。
要点
- NAFLD患者CKD发生风险较无NAFLD者升高(HR 1.22,95%CI 1.04-1.43)。
- NFS≥-1.455者CKD风险升高(HR 1.58,95%CI 1.30-1.92),NFS<-1.455者无显著关联。
- NAFLD可能对肾功能产生不良影响,患者需定期监测肾功能。
核心结论
- 在基线无CKD的大样本成人队列中,NAFLD与CKD发生风险升高相关。
- NAFLD可能对肾功能产生不良影响,患者可能需要仔细监测CKD风险增加。
研究设计与样本
- 回顾性队列研究,纳入41,430名基线无CKD的成年男性和女性(平均年龄48.9岁),于2003年1月1日至2013年12月31日期间接受重复健康检查。
- NAFLD状态通过超声评估,NAFLD严重程度通过NAFLD纤维化评分(NFS)评估。
主要发现
- 随访200,790人年(中位随访4.15年),共识别691例新发CKD病例。
- 比较NAFLD与无NAFLD参与者的CKD多因素校正风险比为1.22(95%CI 1.04-1.43)。
- CKD风险随NAFLD严重程度增加而逐渐升高。
- 与无NAFLD参与者相比,NFS<-1.455者和NFS≥-1.455者的CKD多因素校正风险比分别为1.09(95%CI 0.91-1.32)和1.58(95%CI 1.30-1.92)。
- 该关联在临床相关亚组中保持一致。
关键数值与推荐
- 结局为新发CKD,定义为估算肾小球滤过率低于60ml/min/1.73m²。
临床怎么用
- NAFLD患者可能需要定期监测肾功能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) has been associated with chronic kidney disease (CKD), but cohort studies are limited. We investigated the longitudinal association of NAFLD and its severity with the development of CKD. METHODS: We performed a retrospective cohort study of 41,430 adult men and women (average age, 48.9y) without CKD at baseline who underwent repeated health check-up examinations from January 1, 2003, through December 31, 2013. NAFLD status was assessed by ultrasonography, and NAFLD severity was assessed by the NAFLD fibrosis score (NFS). RESULTS: The outcome was an incident CKD, defined as an estimated glomerular filtration rate less than 60ml/min/1.73m2. During 200,790 person-years of follow-up (median follow-up of 4.15years), we identified 691 incident CKD cases. The multivariable-adjusted hazard ratio for CKD comparing participants with and without NAFLD was 1.22 (95% confidence interval [CI] 1.04-1.43). The risk of CKD increased progressively with increased NAFLD severity. The multivariable-adjusted hazard ratios for CKD comparing participants with NFS <-1.455 and those with NFS ≥-1.455 to participants without NAFLD were 1.09 (95% CI 0.91-1.32) and 1.58 (95% CI 1.30-1.92), respectively. The association was consistent across clinically relevant subgroups. CONCLUSION: In a large cohort of adult men and women without CKD, NAFLD was associated with an increased risk of CKD development. NAFLD may adversely affect renal function and patients may need to be carefully monitored for an increased risk of CKD. LAY SUMMARY: The presence of fatty liver is associated with the future decline of renal function. Thus, fatty liver patients need to be monitored regularly for renal function.
引用
- Sinn DH, Kang D, Jang HR, et al. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study. J Hepatol. 2017. PMID: 28870674. doi:10.1016/j.jhep.2017.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。